A small rescue center in Florida reports that an experimental pill, created by Telomir Pharmaceuticals and tested with medical adviser Dr Michael Roizen, appeared to restore health in two twelve-year-old dogs facing cancer and severe arthritis.
The drug, called Telomir-1, is designed to make telomeres, protective tips of DNA that shorten with age, grow longer. Longer telomeres let stem cells keep repairing the body, which could slow or even reverse signs of aging, early laboratory work suggests.
Encouraged by the compassionate-use cases, the company has begun a small safety study in ten older dogs. Results should be ready for peer review in early 2025, and human trials for arthritis are planned for mid-2025, pending regulators.
These early observations do not prove the pill works, yet they hint that targeting telomeres might one day extend the healthy years of both pets and people.
0 Comments